Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Stimulation Parameters for Spike-ripple Disruption in Patients Undergoing Invasive Monitoring

NCT06141668 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06141668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Stimulation Parameters for Spike-ripple Disruption in Patients Undergoing Invasive Monitoring
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2023
Completion date
June 30, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy